Цени на лекови во Северна Македонија и референтните земји
Пребарајте големопродажни цени на лекови во Северна Македонија, Словенија, Хрватска, Бугарија, Србија и Грција, и пресметајте цена согласно официјалната методологија за формирање на цените на лековите.
Price calculation
| Calc | Country | ATC | INN | Product | Details / pack | MAH | Local price | Wholesale MKD |
|---|
Патот на парите за лековиThe path of money for medicines
Од буџетот на државата до болницата и аптекатаFrom the state budget to the hospital and the pharmacy
- 42 милиони €€42 millionпрограми на Министерството: ретки болести, инсулин, вакциниMinistry programmes: rare diseases, insulin, vaccines
- 123веледрогерии со дејност лековиwholesalers active in medicines
- 102 милиони €€102 millionдостасани долгови на јавните установиoverdue debts of public institutions
- 46%од болничките лекови се цитостатициof hospital medicines are cancer medicines
Ви треба истата слика за вашата молекула, вашата терапевтска група или вашите конкуренти?Need the same picture for your molecule, your therapeutic group or your competitors?
Подготвуваме детални извештаи по нарачка од истите бази на податоци. Секој извештај се прилагодува на потребите на компанијата: опфат, период и ниво на детал.We prepare detailed custom reports from the same databases. Each report is tailored to the company's needs: scope, period and level of detail.
- Тендери по молекула: цени, количини, понудувачиTenders by molecule: prices, volumes, bidders
- Конкурентски преглед по терапевтска групаCompetitor review by therapeutic group
- Трошоци на Фондот и условни буџетиFund spending and conditional budgets
- Профил на установа: набавки, долгови, рокови на плаќањеInstitution profile: purchasing, debts, payment times
- Дистрибутивна мрежа: веледрогерии и аптекиDistribution network: wholesalers and pharmacies
Извори: Буџет на Република Северна Македонија за 2025 (ребаланс); Фонд за здравствено осигурување, извештаи за 2025; Завршна сметка на Буџетот за 2025; e-nabavki.gov.mk; регистри на Агенцијата за лекови (ноември 2026). Министерството е прикажано без трансферот кон Фондот. Курс 61,5 денари за едно евро.Sources: Budget of the Republic of North Macedonia for 2025 (revised); Health Insurance Fund, 2025 reports; Final account of the 2025 Budget; e-nabavki.gov.mk; registers of the Agency for Medicines (November 2026). The Ministry is shown without its transfer to the Fund. Rate 61.5 denars per euro.
Insights
Pricing methodology for medicines
Mapped to the Methodology on the manner of forming the prices of medicines (Government of the Republic of North Macedonia, No. 45-4259/1 of 4 July 2019, consolidated text), adopted under Article 108(10) of the Law on Medicines and Medical Devices.
Reference countries and data sources (Art. 4)
The reference countries are Slovenia, Bulgaria, Croatia, Serbia and Greece. The comparison uses the latest official wholesale price data published by the competent authorities of those countries. If a comparison price cannot be established in any, or in only one, of the five countries, all EU member states serve as reference countries; if the medicine is not authorized in any EU member state, the price in the manufacturer's country applies.
For North Macedonia two official sources are shown side by side: the current wholesale price from the medicines price register, and the maximum wholesale price excluding VAT set by the Ministry of Health in the maximum-price register (shown as “max.” under the Macedonian price, with the ATC code taken from the same register). The difference between the two is the headroom the holder has under the regulated ceiling.
Price basis and the "same medicine" (Art. 5–8)
Comparison is made at the wholesale price level, excluding VAT. The same medicine means the same INN, pharmaceutical form, strength and pack (Art. 6); the comparison price is established separately for each form, strength and pack (Art. 8). Where the same form is absent, related forms may be compared (e.g. tablet – coated tablet – capsule; suspension – syrup – solution), except that prolonged or modified release forms cannot be equated with non-modified forms. Where pack sizes differ, the closest pack is used and the comparison price is calculated per unit and scaled to the pack in question (Art. 7).
Country comparison price — generics (Art. 9)
Maximum wholesale price (Art. 11)
where C₁ and C₂ are the two lowest country comparison prices
If a comparison price exists in only one reference country, the average is taken of that price and the lowest price across all EU member states (Art. 11(3)). Where no comparison price exists at all, the maximum wholesale price derives from the import price plus customs, import costs and wholesale margin, capped at 25% (import price up to EUR 10), 20% (over EUR 10.01) or 15% (over EUR 100.01) of the import price (Art. 11(5)).
Originator medicines (Art. 17)
Biosimilars are priced at no more than 85% of the maximum wholesale price of the corresponding biological medicine; parallel imports at no more than 85% of the formed price of the same or similar authorized medicine (Art. 15, 15-a).
Currency conversion (Art. 10)
Comparison prices in foreign currency are converted to denars at the National Bank of RNM middle exchange rate applicable on the last 1 March preceding the calculation date.
Annual revision (Art. 12)
The Ministry of Health determines the maximum wholesale price once per year on 15 March and publishes it at lekovi.zdravstvo.gov.mk. The MAH is notified of the proposed calculation in advance and may submit objections; a request for price formation must follow within seven days of the determination, failing which the previously formed price ceases to be valid. The newly determined maximum price cannot exceed the existing maximum price (Art. 12(6)).
Retail margins (Art. 14)
- Wholesale price up to EUR 5.00 — retail margin 28%
- EUR 5.01 to 20.00 — margin 25%
- EUR 20.01 to 100.00 — margin 20%
- Above EUR 100.01 — fixed margin of MKD 1,200
How this tool applies the methodology
The calculation panel in the search view computes, from the currently filtered results: the country comparison price per Art. 9 (generic mode: average of all matching prices per country) or per Art. 17 (originator mode: the originator product's price per country); the maximum wholesale price per Art. 11 as the average of the two lowest country values; and an indicative retail price excluding VAT per the Art. 14 margin bands.